Navigation Links
Prosthetic retina offers simple solution to restoring sight
Date:5/17/2012

A device which could restore sight to patients with one of the most common causes of blindness in the developed world is being developed in an international partnership.

Researchers from the University of Strathclyde and Stanford University in California are creating a prosthetic retina for patients of age related macular degeneration (AMD), which affects one in 500 patients aged between 55 and 64 and one in eight aged over 85.

The device would be simpler in design and operation than existing models. It acts by electrically stimulating neurons in the retina, which are left relatively unscathed by the effects of AMD while other 'image capturing' cells, known as photoreceptors, are lost.

It would use video goggles to deliver energy and images directly to the eye and be operated remotely via pulsed near infra-red light- unlike most prosthetic retinas, which are powered through coils that require complex surgery to be implanted.

The prosthetic retina is a thin silicon device that converts pulsed near infra-red light to electrical current that stimulates the retina and elicits visual perception. It requires no wires and would make surgical implantation simpler. The device has been shown to produce encouraging responses in initial lab tests and is reported in an article published in Nature Photonics. The technology is now being developed further.

Dr Keith Mathieson, now a Reader in the Institute of Photonics at the University of Strathclyde in Glasgow, was one of the lead researchers and first author of the paper. He said: "AMD is a huge medical challenge and, with an aging population, is continuing to grow. This means that innovative, practical solutions are essential if sight is to be restored to people around the world with the condition.

"The prosthetic retina we are developing has been partly inspired by cochlear implants for the ear but with a camera instead of a microphone and, where many cochlear implants have a few channels, we are designing the retina to deal with millions of light sensitive nerve cells and sensory outputs.

"The implant is thin and wireless and so is easier to implant. Since it receives information on the visual scene through an infra-red beam projected through the eye, the device can take advantage of natural eye movements that play a crucial role in visual processing."

The research was co-authored by Dr. Jim Loudin of Stanford and led by Professor Daniel Palanker, also of Stanford, and Professor Alexander Sher, of the University of California, Santa Cruz.

Professor Palanker said: "The current implants are very bulky, and the surgery to place the intraocular wiring for receiving, processing and power is difficult. With our device, the surgeon needs only to create a small pocket beneath the retina and then slip the photovoltaic cells inside it."

Dr Mathieson was supported through a fellowship from SU2P, a venture between academic institutions in Scotland and California aimed at extracting economic impact from their joint research portfolio in photonics and related technologies.

Strathclyde leads the collaboration, which also includes Stanford, the Universities of St Andrews, Heriot-Watt and Glasgow and the California Institute of Technology. SU2P was established through funding from Research Councils UK- as part of its Science Bridges awards- the Scottish Funding Council and Scottish Enterprise.

The research links to Photonics and Health Technologies at Strathclyde- two of the principal themes of the University's Technology and Innovation Centre (TIC), a world-leading research and technology centre transforming the way universities, business, and industry collaborate.

Through Health Technologies at Strathclyde, academics work with industry and the health sector to find technologies for earlier, more accurate disease detection and better treatments, as well as life-long disease prevention.


'/>"/>

Contact: Paul Gallagher
paul.gallagher@strath.ac.uk
44-141-548-2370
University of Strathclyde
Source:Eurekalert

Related medicine news :

1. Neuroprosthetics symposium to be webcast live from Worcester Polytechnic Institute Nov. 3
2. University of Louisville surgeons perform first prosthetic bypass graft with patients stem cells at point-of-care
3. Researchers aim for direct brain control of prosthetic arms
4. A new definition for periprosthetic joint infection
5. Rothman at Jefferson research suggests abandon convention in diagnosing periprosthetic joint infection
6. AMD risk on the rise for Asians; retinal vein bypass may help many CRVO patients
7. Hallmark Alzheimers disease changes found in retinas of humans and imaged in live animals
8. UCSD receives NIH Transformative R01 Award for stimulation of neuron regeneration in the retina
9. Treatment of retinal conditions appears to have changed significantly in previous decade
10. Case Western Reserve receives $10M to study retinal disease, develop new treatments
11. Emory Eye Center to host 25th Southeastern Vitreoretinal Seminar (SEVR)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... Advice Media, the industry leader in digital ... companies in North America and has been included in the Inc. 5000 for the second ... honored to be included in the Inc. 5000 rankings for the second year in a ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... ... August 16, 2017 , ... The next Patient Care ... accepted. , Students who successfully complete the seven-week long Patient Care Academy are ... (CNA). The average starting salary for a CNA in Kalamazoo is $24,428.* , As ...
(Date:8/16/2017)... ... August 16, 2017 , ... Greenfield Advisors is honored to be named to ... second year in a row. The Inc. 5000 list honors private businesses across the ... on the list once is a great accomplishment, but for us to be included ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Any Lab ... 5000. The company ranked #4429 on the newly released, 36th annual Inc. 5000 ... a unique look at the most successful companies within the American economy’s most dynamic ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO ... as president, effective Aug. 7, 2017. ... pursue other interests and will serve as president emeritus during ... served us in multiple leadership roles since he joined Diplomat ... and has provided decisive, strategic leadership which continues to benefit ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
Breaking Medicine Technology: